{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T12:24:08Z","timestamp":1788092648953,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K06866"],"award-info":[{"award-number":["22K06866"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K15351"],"award-info":[{"award-number":["21K15351"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Brain"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Angiotensin\u00a0(Ang)-converting-enzyme (ACE) 2 converts Ang II into Ang (1\u20137), which in turn acts on MAS receptors (ACE2\/Ang (1\u20137)\/MAS receptors pathway). This pathway has neuroprotective properties, making it a potential therapeutic target for psychiatric disorders such as depression. Thus, we examined the effects of diminazene aceturate (DIZE), an ACE2 activator, on depressive-like behavior using behavioral, pharmacological, and biochemical assays. To determine whether DIZE or Ang (1\u20137) produce antidepressant-like effects, we measured the duration of immobility of mice in the tail suspension test following their intracerebroventricular administration. Next, we measured the levels of ACE2 activation in the cerebral cortex, prefrontal cortex, hippocampus, and amygdala after DIZE injection, and examined which cell types, including neurons, microglia, and astrocytes, express ACE2 in the hippocampus using immunofluorescence. Administration of DIZE or Ang (1\u20137) significantly shortened the duration of immobility time in the tail suspension test, while this effect was inhibited by the co-administration of the MAS receptor antagonist A779. DIZE activated ACE2 in the hippocampus. ACE2 was localized to neurons, astrocytes, and microglia in the hippocampus. In conclusion, these results suggest that DIZE may act on ACE2-positive cells in the hippocampus where it increases the activity of ACE2, thereby enhancing signaling of the ACE2\/Ang (1\u20137)\/MAS receptor pathway and resulting in antidepressant-like effects.<\/jats:p>","DOI":"10.1186\/s13041-023-01040-y","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T11:02:34Z","timestamp":1686654154000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Activation of angiotensin-converting enzyme 2 produces an antidepressant-like effect via MAS receptors in mice"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4061-0802","authenticated-orcid":false,"given":"Osamu","family":"Nakagawasai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisei","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Yamagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Nemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Tan-No","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,13]]},"reference":[{"key":"1040_CR1","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.bbi.2020.07.037","volume":"89","author":"MG Mazza","year":"2020","unstructured":"Mazza MG, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I, Melloni EMT, Furlan R, Ciceri F, Rovere-Querini P, Benedetti F. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594\u2013600.","journal-title":"Brain Behav Immun"},{"key":"1040_CR2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/nyas.14506","volume":"1486","author":"J Deng","year":"2021","unstructured":"Deng J, Zhou F, Hou W, Silver Z, Wong CY, Chang O, Huang E, Zuo QK. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis. Ann N Y Acad Sci. 2021;1486:90\u2013111.","journal-title":"Ann N Y Acad Sci"},{"key":"1040_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jpsychires.2021.09.054","volume":"144","author":"O Renaud-Charest","year":"2021","unstructured":"Renaud-Charest O, Lui LMW, Eskander S, Ceban F, Ho R, Di Vincenzo JD, Rosenblat JD, Lee Y, Subramaniapillai M, McIntyre RS. Onset and frequency of depression in post-COVID-19 syndrome: a systematic review. J Psychiatr Res. 2021;144:129\u201337.","journal-title":"J Psychiatr Res"},{"key":"1040_CR4","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/nature07455","volume":"455","author":"V Krishnan","year":"2008","unstructured":"Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature. 2008;455:894\u2013902.","journal-title":"Nature"},{"key":"1040_CR5","first-page":"48","volume":"591","author":"JE Hall","year":"1990","unstructured":"Hall JE, Guyton AC, Mizelle HL. Role of the renin-angiotensin system in control of sodium excretion and arterial pressure. Acta Physiol Scand Suppl. 1990;591:48\u201362.","journal-title":"Acta Physiol Scand Suppl"},{"key":"1040_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1113\/jphysiol.2006.126193","volume":"580","author":"PS Leung","year":"2007","unstructured":"Leung PS. The physiology of a local renin-angiotensin system in the pancreas. J Physiol. 2007;580:31\u20137.","journal-title":"J Physiol"},{"key":"1040_CR7","first-page":"639","volume":"52","author":"RM Touyz","year":"2000","unstructured":"Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev. 2000;52:639\u201372.","journal-title":"Pharmacol Rev"},{"key":"1040_CR8","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S1357-2725(02)00271-6","volume":"35","author":"Y Suzuki","year":"2003","unstructured":"Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. Inflammation and angiotensin II. Int J Biochem Cell Biol. 2003;35:881\u2013900.","journal-title":"Int J Biochem Cell Biol"},{"key":"1040_CR9","doi-asserted-by":"publisher","first-page":"R117","DOI":"10.1152\/ajpregu.00476.2002","volume":"285","author":"T Chabrashvili","year":"2003","unstructured":"Chabrashvili T, Kitiyakara C, Blau J, Karber A, Aslam S, Welch WJ, Wilcox CS. Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am J Physiol Regul Integr Comp Physiol. 2003;285:R117\u2013124.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"1040_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11906-018-0845-3","volume":"20","author":"S Patel","year":"2018","unstructured":"Patel S, Hussain T. Dimerization of AT(2) and mas receptors in control of blood pressure. Curr Hypertens Rep. 2018;20:41.","journal-title":"Curr Hypertens Rep"},{"key":"1040_CR11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.kint.2018.07.028","volume":"95","author":"M Kukida","year":"2019","unstructured":"Kukida M, Mogi M, Kan-No H, Tsukuda K, Bai HY, Shan BS, Yamauchi T, Higaki A, Min LJ, Iwanami J, et al. AT2 receptor stimulation inhibits phosphate-induced vascular calcification. Kidney Int. 2019;95:138\u201348.","journal-title":"Kidney Int"},{"key":"1040_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psyneuen.2010.10.001","volume":"36","author":"JM Saavedra","year":"2011","unstructured":"Saavedra JM, S\u00e1nchez-Lemus E, Benicky J. Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: therapeutic implications. Psychoneuroendocrinology. 2011;36:1\u201318.","journal-title":"Psychoneuroendocrinology"},{"key":"1040_CR13","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/0006-3223(86)90334-3","volume":"21","author":"RF Deicken","year":"1986","unstructured":"Deicken RF. Captopril treatment of depression. Biol Psychiatry. 1986;21:1425\u20138.","journal-title":"Biol Psychiatry"},{"key":"1040_CR14","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/0006-3223(88)90010-8","volume":"23","author":"L Germain","year":"1988","unstructured":"Germain L, Chouinard G. Treatment of recurrent unipolar major depression with captopril. Biol Psychiatry. 1988;23:637\u201341.","journal-title":"Biol Psychiatry"},{"key":"1040_CR15","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JOE-12-0341","volume":"216","author":"RA Santos","year":"2013","unstructured":"Santos RA, Ferreira AJ, Verano-Braga T, Bader M. Angiotensin-converting enzyme 2, angiotensin-(1\u20137) and mas: new players of the renin-angiotensin system. J Endocrinol. 2013;216:R1\u2013r17.","journal-title":"J Endocrinol"},{"key":"1040_CR16","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/bph.12159","volume":"169","author":"AC Sim\u00f5es e Silva","year":"2013","unstructured":"Sim\u00f5es e Silva AC, Silveira KD, Ferreira AJ, Teixeira MM. ACE2, angiotensin-(1\u20137) and mas receptor axis in inflammation and fibrosis. Br J Pharmacol. 2013;169:477\u201392.","journal-title":"Br J Pharmacol"},{"key":"1040_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1152\/physrev.00023.2016","volume":"98","author":"RAS Santos","year":"2018","unstructured":"Santos RAS, Sampaio WO, Alzamora AC, Motta-Santos D, Alenina N, Bader M, Campagnole-Santos MJ. The ACE2\/Angiotensin-(1\u20137)\/MAS Axis of the renin-angiotensin system: focus on Angiotensin-(1\u20137). Physiol Rev. 2018;98:505\u201353.","journal-title":"Physiol Rev"},{"key":"1040_CR18","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1161\/01.HYP.0000175813.04375.8a","volume":"46","author":"CH Castro","year":"2005","unstructured":"Castro CH, Santos RA, Ferreira AJ, Bader M, Alenina N, Almeida AP. Evidence for a functional interaction of the angiotensin-(1\u20137) receptor mas with AT1 and AT2 receptors in the mouse heart. Hypertension. 2005;46:937\u201342.","journal-title":"Hypertension"},{"key":"1040_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1161\/HYPERTENSIONAHA.110.152942","volume":"56","author":"SQ Savergnini","year":"2010","unstructured":"Savergnini SQ, Beiman M, Lautner RQ, de Paula-Carvalho V, Allahdadi K, Pessoa DC, Costa-Fraga FP, Fraga-Silva RA, Cojocaru G, Cohen Y, et al. Vascular relaxation, antihypertensive effect, and cardioprotection of a novel peptide agonist of the MAS receptor. Hypertension. 2010;56:112\u201320.","journal-title":"Hypertension"},{"key":"1040_CR20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.phrs.2012.10.014","volume":"67","author":"T Jiang","year":"2013","unstructured":"Jiang T, Gao L, Shi J, Lu J, Wang Y, Zhang Y. Angiotensin-(1\u20137) modulates renin-angiotensin system associated with reducing oxidative stress and attenuating neuronal apoptosis in the brain of hypertensive rats. Pharmacol Res. 2013;67:84\u201393.","journal-title":"Pharmacol Res"},{"key":"1040_CR21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12916-017-0916-3","volume":"15","author":"J Vian","year":"2017","unstructured":"Vian J, Pereira C, Chavarria V, K\u00f6hler C, Stubbs B, Quevedo J, Kim SW, Carvalho AF, Berk M, Fernandes BS. The renin-angiotensin system: a possible new target for depression. BMC Med. 2017;15:144.","journal-title":"BMC Med"},{"key":"1040_CR22","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1177\/1087057111413919","volume":"16","author":"LV Kulemina","year":"2011","unstructured":"Kulemina LV, Ostrov DA. Prediction of off-target effects on angiotensin-converting enzyme 2. J Biomol Screen. 2011;16:878\u201385.","journal-title":"J Biomol Screen"},{"key":"1040_CR23","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1089\/ars.2014.6070","volume":"23","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Liu J, Luo JY, Tian XY, Cheang WS, Xu J, Lau CW, Wang L, Wong WT, Wong CM, et al. Upregulation of angiotensin (1\u20137)-Mediated signaling preserves endothelial function through reducing oxidative stress in diabetes. Antioxid Redox Signal. 2015;23:880\u201392.","journal-title":"Antioxid Redox Signal"},{"key":"1040_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bbr.2013.09.003","volume":"257","author":"LM Kangussu","year":"2013","unstructured":"Kangussu LM, Almeida-Santos AF, Bader M, Alenina N, Fontes MA, Santos RA, Aguiar DC, Campagnole-Santos MJ. Angiotensin-(1\u20137) attenuates the anxiety and depression-like behaviors in transgenic rats with low brain angiotensinogen. Behav Brain Res. 2013;257:25\u201330.","journal-title":"Behav Brain Res"},{"key":"1040_CR25","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1042\/CS20160116","volume":"130","author":"AF Almeida-Santos","year":"2016","unstructured":"Almeida-Santos AF, Kangussu LM, Moreira FA, Santos RA, Aguiar DC, Campagnole-Santos MJ. Anxiolytic- and antidepressant-like effects of angiotensin-(1\u20137) in hypertensive transgenic (mRen2)27 rats. Clin Sci (Lond). 2016;130:1247\u201355.","journal-title":"Clin Sci (Lond)"},{"key":"1040_CR26","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s10072-021-05082-9","volume":"42","author":"RAL De Sousa","year":"2021","unstructured":"De Sousa RAL, Improta-Caria AC, Aras-J\u00fanior R, de Oliveira EM, Soci \u00daPR, Cassilhas RC. Physical exercise effects on the brain during COVID-19 pandemic: links between mental and cardiovascular health. Neurol Sci. 2021;42:1325\u201334.","journal-title":"Neurol Sci"},{"key":"1040_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.brainres.2005.03.048","volume":"1046","author":"JP Voigt","year":"2005","unstructured":"Voigt JP, H\u00f6rtnagl H, Rex A, van Hove L, Bader M, Fink H. Brain angiotensin and anxiety-related behavior: the transgenic rat TGR(ASrAOGEN)680. Brain Res. 2005;1046:145\u201356.","journal-title":"Brain Res"},{"key":"1040_CR28","doi-asserted-by":"publisher","first-page":"H644","DOI":"10.1152\/ajpheart.00210.2013","volume":"305","author":"N Moniwa","year":"2013","unstructured":"Moniwa N, Varagic J, Simington SW, Ahmad S, Nagata S, Voncannon JL, Ferrario CM. Primacy of angiotensin converting enzyme in angiotensin-(1\u201312) metabolism. Am J Physiol Heart Circ Physiol. 2013;305:H644\u2013650.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1040_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.npep.2017.05.002","volume":"65","author":"W Nemoto","year":"2017","unstructured":"Nemoto W, Yamagata R, Ogata Y, Nakagawasai O, Tadano T, Tan-No K. Inhibitory effect of angiotensin (1\u20137) on angiotensin III-induced nociceptive behaviour in mice. Neuropeptides. 2017;65:71\u20136.","journal-title":"Neuropeptides"},{"key":"1040_CR30","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1007\/s00018-018-2815-y","volume":"75","author":"F Klempin","year":"2018","unstructured":"Klempin F, Mosienko V, Matthes S, Villela DC, Todiras M, Penninger JM, Bader M, Santos RAS, Alenina N. Depletion of angiotensin-converting enzyme 2 reduces brain serotonin and impairs the running-induced neurogenic response. Cell Mol Life Sci. 2018;75:3625\u201334.","journal-title":"Cell Mol Life Sci"},{"key":"1040_CR31","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.1083328","volume":"301","author":"L Santarelli","year":"2003","unstructured":"Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O, et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science. 2003;301:805\u20139.","journal-title":"Science"},{"key":"1040_CR32","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1007\/s00213-022-06098-5","volume":"239","author":"AL Pehrson","year":"2022","unstructured":"Pehrson AL, Roberts D, Khawaja A, McNair R. The role of serotonin neurotransmission in rapid antidepressant actions. Psychopharmacology. 2022;239:1823\u201338.","journal-title":"Psychopharmacology"},{"key":"1040_CR33","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/1440-1681.13251","volume":"47","author":"T Qaradakhi","year":"2020","unstructured":"Qaradakhi T, Gadanec LK, McSweeney KR, Tacey A, Apostolopoulos V, Levinger I, Rimarova K, Egom EE, Rodrigo L, Kruzliak P, et al. The potential actions of angiotensin-converting enzyme II (ACE2) activator diminazene aceturate (DIZE) in various diseases. Clin Exp Pharmacol Physiol. 2020;47:751\u20138.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1040_CR34","doi-asserted-by":"publisher","first-page":"104880","DOI":"10.1016\/j.yhbeh.2020.104880","volume":"127","author":"AF Almeida-Santos","year":"2021","unstructured":"Almeida-Santos AF, de Melo LA, Goncalves SCA, Oliveira Amaral LB, Santos RAS, Campagnole-Santos MJ, Kangussu LM. Alamandine through MrgD receptor induces antidepressant-like effect in transgenic rats with low brain angiotensinogen. Horm Behav. 2021;127:104880.","journal-title":"Horm Behav"},{"key":"1040_CR35","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1113\/expphysiol.2011.058578","volume":"96","author":"AP Mecca","year":"2011","unstructured":"Mecca AP, Regenhardt RW, O\u2019Connor TE, Joseph JP, Raizada MK, Katovich MJ, Sumners C. Cerebroprotection by angiotensin-(1\u20137) in endothelin-1-induced ischaemic stroke. Exp Physiol. 2011;96:1084\u201396.","journal-title":"Exp Physiol"},{"key":"1040_CR36","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1248\/bpb.b21-01078","volume":"45","author":"O Nakagawasai","year":"2022","unstructured":"Nakagawasai O, Takahashi K, Ambo A, Onuma K, Takahashi N, Nemoto W, Tan-No K. Antidepressant effect of intracerebroventricularly administered deltorphin analogs in the mouse tail suspension test. Biol Pharm Bull. 2022;45:538\u201341.","journal-title":"Biol Pharm Bull"},{"key":"1040_CR37","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jphs.2020.01.002","volume":"143","author":"O Nakagawasai","year":"2020","unstructured":"Nakagawasai O, Yamada K, Odaira T, Takahashi K, Nemoto W, Sakuma W, Wakou M, Lin JR, Tan-No K. Liver hydrolysate improves depressive-like behavior in olfactory bulbectomized mice: involvement of hippocampal neurogenesis through the AMPK\/BDNF\/CREB pathway. J Pharmacol Sci. 2020;143:52\u20135.","journal-title":"J Pharmacol Sci"},{"key":"1040_CR38","doi-asserted-by":"publisher","first-page":"112640","DOI":"10.1016\/j.bbr.2020.112640","volume":"390","author":"O Nakagawasai","year":"2020","unstructured":"Nakagawasai O, Yamada K, Takahashi K, Odaira T, Sakuma W, Ishizawa D, Takahashi N, Onuma K, Hozumi C, Nemoto W, Tan-No K. Liver hydrolysate prevents depressive-like behavior in an animal model of colitis: involvement of hippocampal neurogenesis via the AMPK\/BDNF pathway. Behav Brain Res. 2020;390:112640.","journal-title":"Behav Brain Res"},{"key":"1040_CR39","doi-asserted-by":"crossref","unstructured":"Nakagawasai O, Yamada K, Sakuma W, Takahashi K, Odaira T, Yamagata R, Nemoto W, Ejima A, Sato K, Tan-No K. A novel dipeptide derived from porcine liver hydrolysate induces recovery from physical fatigue in a mouse model. J Funct Foods 2021, 76.","DOI":"10.1016\/j.jff.2020.104312"},{"key":"1040_CR40","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jphs.2022.01.009","volume":"148","author":"O Nakagawasai","year":"2022","unstructured":"Nakagawasai O, Takahashi K, Miura Y, Nemoto W, Obara Y, Tan-No K. ERK5 inhibitor BIX02189 attenuates methamphetamine-induced hyperactivity by modulating microglial activation in the striatum. J Pharmacol Sci. 2022;148:326\u201330.","journal-title":"J Pharmacol Sci"},{"key":"1040_CR41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jpsychires.2022.01.047","volume":"148","author":"K Takahashi","year":"2022","unstructured":"Takahashi K, Kurokawa K, Hong L, Miyagawa K, Mochida-Saito A, Iwasa M, Iwasa H, Nakagawasai O, Tadano T, Takeda H, Tsuji M. Antidepressant effects of Enterococcus faecalis 2001 through the regulation of prefrontal cortical myelination via the enhancement of CREB\/BDNF and NF-kappaB p65\/LIF\/STAT3 pathways in olfactory bulbectomized mice. J Psychiatr Res. 2022;148:137\u201348.","journal-title":"J Psychiatr Res"},{"key":"1040_CR42","doi-asserted-by":"publisher","first-page":"583291","DOI":"10.3389\/fphar.2020.583291","volume":"11","author":"O Nakagawasai","year":"2020","unstructured":"Nakagawasai O, Lin JR, Odaira T, Takahashi K, Nemoto W, Moriguchi S, Yabuki Y, Kobayakawa Y, Fukunaga K, Nakada M, Tan-No K. Scabronine G Methyl Ester improves memory-related behavior and enhances hippocampal cell proliferation and long-term potentiation via the BDNF-CREB pathway in olfactory Bulbectomized mice. Front Pharmacol. 2020;11:583291.","journal-title":"Front Pharmacol"},{"key":"1040_CR43","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12974-019-1580-7","volume":"16","author":"K Takahashi","year":"2019","unstructured":"Takahashi K, Nakagawasai O, Nemoto W, Odaira T, Sakuma W, Onogi H, Nishijima H, Furihata R, Nemoto Y, Iwasa H, et al. Effect of Enterococcus faecalis 2001 on colitis and depressive-like behavior in dextran sulfate sodium-treated mice: involvement of the brain-gut axis. J Neuroinflammation. 2019;16:201.","journal-title":"J Neuroinflammation"},{"key":"1040_CR44","doi-asserted-by":"publisher","first-page":"113825","DOI":"10.1016\/j.bcp.2020.113825","volume":"174","author":"R Yamagata","year":"2020","unstructured":"Yamagata R, Nemoto W, Nakagawasai O, Takahashi K, Tan-No K. Downregulation of spinal angiotensin converting enzyme 2 is involved in neuropathic pain associated with type 2 diabetes mellitus in mice. Biochem Pharmacol. 2020;174:113825.","journal-title":"Biochem Pharmacol"}],"container-title":["Molecular Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-023-01040-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13041-023-01040-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-023-01040-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T12:06:35Z","timestamp":1686657995000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularbrain.biomedcentral.com\/articles\/10.1186\/s13041-023-01040-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,13]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1040"],"URL":"https:\/\/doi.org\/10.1186\/s13041-023-01040-y","relation":{},"ISSN":["1756-6606"],"issn-type":[{"value":"1756-6606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,13]]},"assertion":[{"value":"29 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experiments were performed in accordance with the Guide for the Care and Use of Laboratory Animals from the Tohoku Medical and Pharmaceutical University (Approval number: 20051-cn, 21035-cn) and the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Efforts were made to minimize suffering and to reduce the number of animals used.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"52"}}